Among children treated with an oral agent, the recurrence rate was 16/42 (38.1%) following penicillin or amoxicillin and 10/36 (27.8%) following a beta-lactamase resistant agent (adjusted odds ...

Beta-lactamase inhibitors are designed to overcome a key resistance mechanism that allows pathogens to protect themselves from beta-lactams, one of the most commonly-used antibiotic classes.

We aimed to evaluate the prevalence of plasmid-mediated-quinolone-resistance (PMQR) and extended-spectrum beta-lactamase- (ESBL) producing gram-negative organisms among primigravid women with ...

In a lecture at VMX, Jason B. Pieper, DVM, MS, DACVD, outlined the next steps in the treatment of pyoderma in dogs when the ...

While these multidrug-resistant UTIs have long been a problem in hospitals and other healthcare facilities where patients are routinely exposed to bacterial pathogens and antibiotics, the incidence of ...

such as ESBL/pAmpC/carbapenemase-producing Enterobacteriaceae and livestock-associated methicillin-resistant Staphylococcus aureus. Our studies also aim towards implementing strategies to prevent ...

More than half of the E coli isolates tested were multidrug resistant (MDR), and nearly 60% were found to harbor extended-spectrum beta lactamase (ESBL), an enzyme that confers resistance to ...

This study reports a high prevalence of ESBL-PE associated with strong resistance to quinolones and cotrimoxazole (over 80%), which calls for increased surveillance of these superbugs, the adoption of ...

Thereby, bacterial resistance is developing the beta-lactam antibiotics. Beta-lactamase enzymes are produced either constitutively or on exposure to antimicrobials. These enzymes break the beta-lactam ...

This rate is higher than observed in children treated with a beta-lactamase resistant agent, although the associated risk estimate reached statistical significance (pooled OR: 2.39 [95% CI ...